onco pharma
Trade trend analysis
Mon
|
Year
Number of Transactions Quantity Weight
Number of Transactions Quantity Weight
The above chart presents the market trend analysis for onco pharma from 2025 to 2026. By examining various dimensions such as transaction quantity, transaction weight, average price, and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability. As of 2026, the company has completed 23 transactions, with a transaction quantity of 26.37 and a transaction weight of 0.
- Year Transactions Quantity Weight
- 2025 0 0 0
- 2026 23 26.37 0
Bill of lading data
< 1/15 >- Trade date 2026/06/30 B/L No. ——
- Suppliers clinigen ireland ltd. Buyers onco pharma
- POLs —— PODs ipaf
- Supply area United States Purchas area Pakistan
- Weight —— Amount 6619.35275
- Hs code 30049099 Product tags cancer,c#,pro,mab,nivolumab,medicine,shah,atl
- Product description MEDICINE FOR CANCER PATIENT (MR. SHAHID IQBAL CNIC# 35302-6966463-3) SUPPLIED AS PER ACCESS PROGRAM- Nivolumab 240mg+ Relatlimab 80mg 20ml inj QTY 8 NT WT 0.160 KGS. Expand
- Trade date 2026/06/23 B/L No. ——
- Suppliers clinigen ireland ltd. Buyers onco pharma
- POLs —— PODs kpfi
- Supply area England Purchas area Pakistan
- Weight —— Amount 3207.197555
- Hs code 30049099 Product tags ion,rat,lumi,gin,opdivo,bran,gh
- Product description OPDIVO NIVOLUMIB 240/MG /24ML 10MG/ML ( Expiration Date: June 2028 (Lot: 2204244)NET WEIGHT 0.144 KGS. BRAND: OPDIVO & ORIGIN: USA Expand
- Trade date 2026/06/18 B/L No. ——
- Suppliers recordati rare diseases inc. Buyers onco pharma
- POLs —— PODs kpfi
- Supply area France Purchas area Pakistan
- Weight —— Amount 1187.519769
- Hs code 30049099 Product tags bat,expiry date,t2,pc,capsule,tag,ys,n 15
- Product description CYSTAGON 150mg -100 CAPSULES BATCH T2507X03 MFG DATE 11-04-2025 EXPIRY DATED 31-03-2027 ...QTY 4 PCS Expand
- Trade date 2026/06/18 B/L No. ——
- Suppliers recordati rare diseases inc. Buyers onco pharma
- POLs —— PODs kpfi
- Supply area France Purchas area Pakistan
- Weight —— Amount 296.879942
- Hs code 30049099 Product tags bat,expiry date,t2,france,pc,capsule,tag,gin,ys,n 15,bran
- Product description CYSTAGON 150mg -100 CAPSULES BATCH T2507X03 MFG DATE 11-04-2025 EXPIRY DATED 31-03-2027 QTY 1 PCS BRAND: Cystagon & ORIGIN: FRANCE Expand
- Trade date 2026/06/18 B/L No. ——
- Suppliers clinigen ireland ltd. Buyers onco pharma
- POLs —— PODs ipaf
- Supply area United States Purchas area Pakistan
- Weight —— Amount 4276.258087
- Hs code 30049099 Product tags asim,cancer,c#,pro,lumi,medicine,shah,injection
- Product description MEDICINE FOR CANCER PATIENT (MR. SYED QASIM ALI SHAH CNIC# 71404-0342931-9) SUPPLIED AS PER ACCESS PROGRAM- NIVOLUMIB 240/MG /24ML 10MG/ML inj 1 vls QTY 8 INJECTIONS NT WT 0.160 KGS. Expand
- Trade date 2026/06/18 B/L No. ——
- Suppliers clinigen ireland ltd. Buyers onco pharma
- POLs —— PODs ipaf
- Supply area United States Purchas area Pakistan
- Weight —— Amount 4717.652767
- Hs code 30049099 Product tags sht,cancer,c#,pro,lumi,medicine
- Product description MEDICINE FOR CANCER PATIENT (MR. ADIL ISHTIAQ CNIC# 34603-3198850-5) SUPPLIED AS PER ACCESS PROGRAM- NIVOLUMIB 240/MG /24ML 10MG/ML inj 1 vls QTY 12 NT WT 0.180 KGS. Expand
- Trade date 2026/06/13 B/L No. ——
- Suppliers clinigen ireland ltd. Buyers onco pharma
- POLs —— PODs kpfi
- Supply area United States Purchas area Pakistan
- Weight —— Amount 4276.25876
- Hs code 30049099 Product tags cancer,pro,delivery,release,amine,lumi,medicine,opdivo,dy e,gh
- Product description MEDICINE ALREADY EXAMINED AND RELEASED DELIVERY TO CANCER PATIENT MEDICINE SUPPLIED AS PER ACCESS PROGRAM- OPDIVO NIVOLUMIB 240/MG /24ML 10MG/ML NET WEIGHT 0.192 KGS. Expand
- Trade date 2026/06/08 B/L No. ——
- Suppliers clinigen ireland ltd. Buyers onco pharma
- POLs —— PODs kpfi
- Supply area United States Purchas area Pakistan
- Weight —— Amount 4276.255839
- Hs code 30049099 Product tags lumi,medicine,gin,opdivo,bran,gh
- Product description MEDICINE - OPDIVO NIVOLUMIB 240/MG /24ML 10MG/ML NET WEIGHT 0.192 KGS. LOT NO . 2204244 30/06/2028 BRAND: Opdivo & ORIGIN: USA Expand
- Trade date 2026/06/08 B/L No. ——
- Suppliers clinigen ireland ltd. Buyers onco pharma
- POLs —— PODs ipaf
- Supply area United States Purchas area Pakistan
- Weight —— Amount 3207.193675
- Hs code 30049099 Product tags cancer,c#,pro,ail,lumi,medicine,mma
- Product description MEDICINE FOR CANCER PATIENT (MR. MUHAMMAD SOHAIL CNIC# 33106-8948956-9) SUPPLIED AS PER ACCESS PROGRAM- NIVOLUMIB 240/MG /24ML 10MG/ML inj 1 vls QTY 6 NT WT 0.144 KGS. Man. Date: 30-06-2025 Exp. Date: 30-06-2028 Expand
- Trade date 2026/06/06 B/L No. ——
- Suppliers clinigen ireland ltd. Buyers onco pharma
- POLs —— PODs kpfi
- Supply area Ireland Purchas area Pakistan
- Weight —— Amount 4736.787639
- Hs code 30049099 Product tags eland,expiry date,vial,lumi,gin,opdivo,umber,bran,gh
- Product description OPDIVO NIVOLUMIB 240/MG /24ML 10MG/ML NET WEIGHT 0.144 KGS QTY 12 VIALS Lot Number 2204244 Expiry Date JUN 2028 BRAND: Opdivo & ORIGIN: IRELAND Expand
- Trade date 2026/05/19 B/L No. ——
- Suppliers clinigen ireland ltd. Buyers onco pharma
- POLs —— PODs kpfi
- Supply area Ireland Purchas area Pakistan
- Weight —— Amount 5879.845601
- Hs code 30049099 Product tags cancer,pro,delivery,release,amine,lumi,medicine,opdivo,dy e,gh
- Product description MEDICINE ALREADY EXAMINED AND RELEASED DELIVERY TO CANCER PATIENT MEDICINE SUPPLIED AS PER ACCESS PROGRAM- OPDIVO NIVOLUMIB 240/MG /24ML 10MG/ML NET WEIGHT 0.264 KGS. Expand
- Trade date 2026/05/19 B/L No. ——
- Suppliers clinigen ireland ltd. Buyers onco pharma
- POLs —— PODs kpfi
- Supply area Ireland Purchas area Pakistan
- Weight —— Amount 3207.188509
- Hs code 30049099 Product tags cancer,pro,delivery,release,amine,lumi,medicine,opdivo,dy e,gh
- Product description MEDICINE ALREADY EXAMINED AND RELEASED DELIVERY TO CANCER PATIENT MEDICINE SUPPLIED AS PER ACCESS PROGRAM- OPDIVO NIVOLUMIB 240/MG /24ML 10MG/ML NET WEIGHT 0.144 KGS. Expand
- Trade date 2026/05/11 B/L No. ——
- Suppliers clinigen ireland ltd. Buyers onco pharma
- POLs —— PODs ipaf
- Supply area United States Purchas area Pakistan
- Weight —— Amount 3207.185929
- Hs code 30049099 Product tags drap,vial,ice,dose,ail,nivolumab,atta,pdi,d can,injection,gh
- Product description FOUND CANCER INJECTION AND DETAIL IS AS UNDER:- 1. OPDIVE (NIVOLUMAB) INJECTION 240MG/ 24ML (10MG/ML) SINGLE DOSE VIAL LOT NO: 2204244 EXPIRE DATE: 06/2028 QTY=06 VIALS. NET WEIGHT: 0.12 KGS. INVOICE/DRAP COC SCANNED ATTACHED Expand
- Trade date 2026/05/04 B/L No. ——
- Suppliers clinigen ireland ltd. Buyers onco pharma
- POLs —— PODs kpfi
- Supply area Netherlands Purchas area Pakistan
- Weight —— Amount 3741.715105
- Hs code 30049099 Product tags cancer,pro,delivery,release,amine,lumi,medicine,opdivo,dy e,gh
- Product description MEDICINE ALREADY EXAMINED AND RELEASED DELIVERY TO CANCER PATIENT MEDICINE SUPPLIED AS PER ACCESS PROGRAM- OPDIVO NIVOLUMIB 240/MG /24ML 10MG/ML NET WEIGHT 0.168 KGS. Expand
- Trade date 2026/05/04 B/L No. ——
- Suppliers clinigen ireland ltd. Buyers onco pharma
- POLs —— PODs kpfi
- Supply area Netherlands Purchas area Pakistan
- Weight —— Amount 4239.458198
- Hs code 30049099 Product tags cancer,pro,delivery,release,amine,lumi,medicine,opdivo,dy e,gh
- Product description MEDICINE ALREADY EXAMINED AND RELEASED DELIVERY TO CANCER PATIENT MEDICINE SUPPLIED AS PER ACCESS PROGRAM- OPDIVO NIVOLUMIB 240/MG /24ML 10MG/ML NET WEIGHT 0.192 KGS. Expand
Partners
Total 7- Rank Company Transactions Per Detail
- 1 clinigen ireland ltd. irelandsupplier,they trade on 2026-06-30 20 57.14% >
- 2 celon laboratories ltd. indiabuyer,they trade on 2022-03-21 6 17.14% >
- 3 krypton global health indiasupplier,they trade on 2016-09-12 3 8.57% >
- 4 therdose pharma pvt ltd. indiabuyer,they trade on 2018-03-16 2 5.71% >
- 5 recordati rare diseases inc. francesupplier,they trade on 2026-06-18 2 5.71% > +View All
Products
Total 3- Products Transactions Per Detail
-
acti
4 100% > -
dactinomycin
4 100% > -
ice
1 25% >
Hscode rank
Total 0- HSCode Name Transactions Per Detail
- HS 30049046 4 100% >
Trading Area
Total 8- Area Transactions Per Detail
- india 11 31.43% >
- netherlands 8 22.86% >
- united states 7 20.00% >
- ireland 4 11.43% >
- france 2 5.71% > +View All
Port statistics
Total 5- Port Name Transactions Per Detail
- kpfi 16 45.71% >
- entebbe 9 25.71% >
- ipaf 5 14.29% >
- kpaf 3 8.57% >
- kampala 2 5.71% >
onco pharma is uganda Buyer,
and primarily engages in the import and export business of products such as acti，dactinomycin，ice.
According to the 52wmb.com global trade database, as of 2026-06-30, the company has completed 35 international trades,
with its main trading regions covering india，netherlands,united states etc.
The core products include HS30049046 etc,
often transported via kpfi，port entebbe, port ipaf etc,
and its main trading partners are clinigen ireland ltd.，celon laboratories ltd.，krypton global health.
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on onco pharma is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.
Reference contact info
Email Hunting Tool